Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Gene mutations can cause problems in male genital development.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

The patient had complex urinary tract issues and ambiguous genitalia, with physical features suggesting a hormonal imbalance.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Mouse genital development depends on male or female hormones for specific features.

Young men's erectile dysfunction is linked to mental health issues and risky behaviors promoted by online communities, highlighting the need for better mental health support and healthy masculinity standards.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Early investigation and a team approach are crucial for managing primary amenorrhea effectively.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.